Optimize the integration of Biocytogen’s fast and efficient target discovery and antibody development platforms, RenLite common light-chain mouse platform and the bispecific antibody assembly platform with independent intellectual property rights, an...
Biocytogen has developed a streamlined BsAb ADC discovery platform, using RenLite Mice, which generates fully human antibodies carrying a common light chain, and Project Integrum to discover more antibodies with more epitope and sequence diversities...